IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-441) (VH (HOMO SAPIENS IGHV3-30*01 (95.8%)-(IGHD)- IGHJ5*01 (100%), CDR-IMGT (8.8.7) (26-33.51-58.97- 103)) (1-114)-HOMO SAPIENS IGHG4*01, G4V5 H P10 (CH1 (115-212), HINGE 1-12 S10>P (222) (213-224), CH2 (225-334), CH3 (335-439), CHS (440-441)) (115- 441)), (128-220')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-220') (V-KAPPA (HOMO SAPIENS IGKV2- 40*01 (94.1%)-IGKJ3*01 (91.7%) P120>Q (106), CDR-IMGT (12.3.9) (27-38.56-58.95-103)) (1'-113')- HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159), V101 (197) (114'-220')); DIMER (220-220'':223-223'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA
Advanced Solid Tumors
Y Biologics Inc.monoclonal_antibodyPhase 1/2Dormant
CC
40/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 59/ 100
Competitive context
1412 Active assets in the Advanced Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nabiximols Jazz Pharmaceuticals | Phase 3 | BBB |
Inno-206 M.D. Anderson Cancer Center | Phase 2 | BB |
Vitamin B6 M.D. Anderson Cancer Center | Phase 4 | BB |
PROPOFOL Hong Kong Children's Hospital | Phase 4 | BB |
Rivoceranib Jiangsu HengRui Medicine Co., Ltd. | Phase 4 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →